| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Aug 14, 2025 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 43.8 | -2,937 | -0.38% | ✗ | $39.9K |
| Jan 6, 2025 | Jan 8, 2025 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 20.0 | -15,162 | -1.94% | ✗ | $308.3K |
| Nov 7, 2024 | Nov 12, 2024 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 38.8 | -15,558 | -2.17% | ✓ | $465.3K |
| Aug 20, 2024 | Aug 22, 2024 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 45.0 | -8,353 | -1.18% | ✓ | $200.4K |
| Aug 13, 2024 | Aug 15, 2024 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 40.0 | -2,272 | -0.32% | ✗ | $52K |
| Feb 13, 2024 | Feb 15, 2024 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 35.0 | -22,844 | -3.11% | ✓ | $402.4K |
| Jan 5, 2024 | Jan 9, 2024 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 22.5 | -9,972 | -1.44% | ✗ | $193.8K |
| Aug 23, 2023 | Aug 25, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 48.8 | -2,522 | -0.39% | ✓ | $58.4K |
| Aug 21, 2023 | Aug 23, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 40.0 | -2,478 | -0.38% | ✗ | $56K |
| Aug 14, 2023 | Aug 16, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 48.8 | -2,772 | -0.43% | ✓ | $65.6K |
| Aug 10, 2023 | Aug 14, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 40.0 | -2,853 | -0.44% | ✗ | $69K |
| Jul 17, 2023 | Jul 19, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 38.8 | -19,702 | -2.94% | ✓ | $587.2K |
| May 15, 2023 | May 17, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 42.5 | -10,000 | -1.49% | ✓ | $286K |
| Apr 12, 2023 | Apr 14, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 45.0 | -10,000 | -0.83% | ✓ | $250.4K |
| Feb 13, 2023 | Feb 15, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 32.5 | -3,497 | -0.53% | ✗ | $105.2K |
| Feb 8, 2023 | Feb 10, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 43.8 | -1,521 | -0.24% | ✗ | $47K |
| Jan 17, 2023 | Jan 19, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 42.5 | -10,000 | -1.54% | ✓ | $295.3K |
| Jan 5, 2023 | Jan 9, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 40.0 | -2,636 | -0.41% | ✗ | $75K |
| Jan 4, 2023 | Jan 9, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 32.5 | -2,912 | -0.59% | ✗ | $83.6K |
| Jan 3, 2023 | Jan 5, 2023 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 90.0 | +38,208 | 5.02% | ✗ | $83.6K |
| Aug 19, 2022 | Aug 23, 2022 | Denali Therapeutics Inc. | COFO and Secretary | Sell | 40.0 | -2,576 | -0.44% | ✗ | $85.6K |
| Feb 11, 2022 | Feb 15, 2022 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -2,803 | -0.49% | ✗ | $97.2K |
| Feb 9, 2022 | Feb 11, 2022 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -1,423 | -0.25% | ✗ | $52.8K |
| Jan 5, 2022 | Jan 7, 2022 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -2,846 | -0.50% | ✗ | $127.4K |
| Dec 6, 2021 | Dec 8, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.82% | ✓ | $422.7K |
| Nov 4, 2021 | Nov 8, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.79% | ✓ | $528.4K |
| Oct 4, 2021 | Oct 6, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.76% | ✓ | $505.6K |
| Sep 7, 2021 | Sep 9, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.75% | ✓ | $555.5K |
| Aug 19, 2021 | Aug 23, 2021 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -2,544 | -0.44% | ✗ | $126.2K |
| Aug 4, 2021 | Aug 6, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.72% | ✓ | $522.2K |
| Jul 6, 2021 | Jul 8, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.69% | ✓ | $762K |
| Jun 4, 2021 | Jun 8, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.66% | ✓ | $645.5K |
| May 4, 2021 | May 6, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.63% | ✓ | $554.9K |
| Apr 5, 2021 | Apr 6, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.61% | ✓ | $560.9K |
| Mar 4, 2021 | Mar 4, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.58% | ✓ | $610.2K |
| Feb 11, 2021 | Feb 16, 2021 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -3,047 | -0.48% | ✗ | $214.3K |
| Feb 7, 2021 | Feb 11, 2021 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -1,468 | -0.27% | ✗ | $109.8K |
| Feb 4, 2021 | Feb 5, 2021 | Denali Therapeutics Inc. | COO | Sell | 42.5 | -10,000 | -1.80% | ✓ | $678.4K |
| Jan 4, 2021 | Jan 6, 2021 | Denali Therapeutics Inc. | COO | Sell | 18.8 | -70,000 | -11.20% | ✓ | $5.2M |
| Aug 20, 2020 | Nov 30, 2020 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -1,954 | -0.31% | ✗ | $64.2K |
| Aug 20, 2020 | Aug 24, 2020 | Denali Therapeutics Inc. | COO | Sell | 40.0 | -1,954 | -0.31% | ✗ | $64.2K |
| Mar 30, 2020 | Apr 1, 2020 | Denali Therapeutics Inc. | COO | Sell | 43.8 | -1,427 | -0.23% | ✗ | $27.8K |
| Dec 3, 2019 | Dec 5, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.17% | ✓ | $135K |
| Nov 22, 2019 | Nov 26, 2019 | Denali Therapeutics Inc. | COO | Sell | 38.8 | -15,000 | -2.40% | ✓ | $270.3K |
| Sep 9, 2019 | Sep 11, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.17% | ✓ | $136.2K |
| Aug 20, 2019 | Aug 22, 2019 | Denali Therapeutics Inc. | COO | Sell | 43.8 | -1,975 | -0.31% | ✗ | $36.7K |
| Aug 7, 2019 | Aug 9, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.17% | ✓ | $141.1K |
| Jul 8, 2019 | Jul 10, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.15% | ✓ | $152.1K |
| Jun 10, 2019 | Jun 12, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.14% | ✓ | $140.8K |
| May 9, 2019 | May 13, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.13% | ✓ | $165.4K |
| Apr 9, 2019 | Apr 11, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.12% | ✓ | $210.4K |
| Mar 11, 2019 | Mar 13, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.11% | ✓ | $169.3K |
| Feb 8, 2019 | Feb 12, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.09% | ✓ | $143.1K |
| Jan 9, 2019 | Jan 11, 2019 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.08% | ✓ | $152.8K |
| Dec 10, 2018 | Dec 12, 2018 | Denali Therapeutics Inc. | COO | Sell | 45.0 | -7,500 | -1.07% | ✓ | $153K |